Dengue Vaccines Industry Research Report 2023

Dengue Vaccines Industry Research Report 2023


Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

Highlights

The global Dengue Vaccines market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.
The Dengue Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dengue Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi
Takeda

Product Type Insights

Global markets are presented by Dengue Vaccines type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Dengue Vaccines are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Dengue Vaccines segment by Type

Dengvaxia
TAK-003
Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Dengue Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Dengue Vaccines market.
Dengue Vaccines Segment by Application

Public Sector
Private Sector

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Dengue Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengue Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Dengue Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Dengue Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengue Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dengue Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Dengue Vaccines by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Dengvaxia
1.2.3 TAK-003
1.2.4 Others
2.3 Dengue Vaccines by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Public Sector
2.3.3 Private Sector
2.4 Assumptions and Limitations
3 Dengue Vaccines Breakdown Data by Type
3.1 Global Dengue Vaccines Historic Market Size by Type (2018-2023)
3.2 Global Dengue Vaccines Forecasted Market Size by Type (2023-2028)
4 Dengue Vaccines Breakdown Data by Application
4.1 Global Dengue Vaccines Historic Market Size by Application (2018-2023)
4.2 Global Dengue Vaccines Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Dengue Vaccines Market Perspective (2018-2029)
5.2 Global Dengue Vaccines Growth Trends by Region
5.2.1 Global Dengue Vaccines Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Dengue Vaccines Historic Market Size by Region (2018-2023)
5.2.3 Dengue Vaccines Forecasted Market Size by Region (2024-2029)
5.3 Dengue Vaccines Market Dynamics
5.3.1 Dengue Vaccines Industry Trends
5.3.2 Dengue Vaccines Market Drivers
5.3.3 Dengue Vaccines Market Challenges
5.3.4 Dengue Vaccines Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Dengue Vaccines Players by Revenue
6.1.1 Global Top Dengue Vaccines Players by Revenue (2018-2023)
6.1.2 Global Dengue Vaccines Revenue Market Share by Players (2018-2023)
6.2 Global Dengue Vaccines Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Dengue Vaccines Head office and Area Served
6.4 Global Dengue Vaccines Players, Product Type & Application
6.5 Global Dengue Vaccines Players, Date of Enter into This Industry
6.6 Global Dengue Vaccines Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Dengue Vaccines Market Size (2018-2029)
7.2 North America Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Dengue Vaccines Market Size by Country (2018-2023)
7.4 North America Dengue Vaccines Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Dengue Vaccines Market Size (2018-2029)
8.2 Europe Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Dengue Vaccines Market Size by Country (2018-2023)
8.4 Europe Dengue Vaccines Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Dengue Vaccines Market Size (2018-2029)
9.2 Asia-Pacific Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Dengue Vaccines Market Size by Country (2018-2023)
9.4 Asia-Pacific Dengue Vaccines Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Dengue Vaccines Market Size (2018-2029)
10.2 Latin America Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Dengue Vaccines Market Size by Country (2018-2023)
10.4 Latin America Dengue Vaccines Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Dengue Vaccines Market Size (2018-2029)
11.2 Middle East & Africa Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Dengue Vaccines Market Size by Country (2018-2023)
11.4 Middle East & Africa Dengue Vaccines Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Dengue Vaccines Introduction
11.1.4 Sanofi Revenue in Dengue Vaccines Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Dengue Vaccines Introduction
11.2.4 Takeda Revenue in Dengue Vaccines Business (2017-2022)
11.2.5 Takeda Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Dengue Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Dengue Vaccines Revenue Market Share by Type (2018-2023)
Table 7. Global Dengue Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Dengue Vaccines Revenue Market Share by Type (2024-2029)
Table 9. Global Dengue Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Dengue Vaccines Revenue Market Share by Application (2018-2023)
Table 11. Global Dengue Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Dengue Vaccines Revenue Market Share by Application (2024-2029)
Table 13. Global Dengue Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Dengue Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Dengue Vaccines Market Share by Region (2018-2023)
Table 16. Global Dengue Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Dengue Vaccines Market Share by Region (2024-2029)
Table 18. Dengue Vaccines Market Trends
Table 19. Dengue Vaccines Market Drivers
Table 20. Dengue Vaccines Market Challenges
Table 21. Dengue Vaccines Market Restraints
Table 22. Global Top Dengue Vaccines Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Dengue Vaccines Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Dengue Vaccines Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Dengue Vaccines, Headquarters and Area Served
Table 26. Global Dengue Vaccines Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Dengue Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Dengue Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Dengue Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Dengue Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Dengue Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Dengue Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Dengue Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Dengue Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Dengue Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Dengue Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Dengue Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Dengue Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Dengue Vaccines Product
Table 48. Sanofi Revenue in Dengue Vaccines Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Takeda Company Detail
Table 51. Takeda Business Overview
Table 52. Takeda Dengue Vaccines Product
Table 53. Takeda Revenue in Dengue Vaccines Business (2017-2022) & (US$ Million)
Table 54. Takeda Recent Development
Table 55. Sanofi Company Information
Table 56. Sanofi Business Overview
Table 57. Sanofi Dengue Vaccines Revenue in Dengue Vaccines Business (2018-2023) & (US$ Million)
Table 58. Sanofi Revenue in Dengue Vaccines Business (2018-2023) & (US$ Million) Portfolio
Table 59. Sanofi Recent Development
Table 60. Takeda Company Information
Table 61. Takeda Business Overview
Table 62. Takeda Dengue Vaccines Revenue in Dengue Vaccines Business (2018-2023) & (US$ Million)
Table 63. Takeda Revenue in Dengue Vaccines Business (2018-2023) & (US$ Million) Portfolio
Table 64. Takeda Recent Development
Table 65. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dengue Vaccines Product Picture
Figure 5. Global Dengue Vaccines Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Dengue Vaccines Market Share by Type: 2022 VS 2029
Figure 7. Dengvaxia Product Picture
Figure 8. TAK-003 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Dengue Vaccines Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Dengue Vaccines Market Share by Application: 2022 VS 2029
Figure 12. Public Sector Product Picture
Figure 13. Private Sector Product Picture
Figure 14. Global Dengue Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Dengue Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Dengue Vaccines Market Share by Region: 2022 VS 2029
Figure 17. Global Dengue Vaccines Market Share by Players in 2022
Figure 18. Global Dengue Vaccines Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Dengue Vaccines Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Dengue Vaccines Market Share by Country (2018-2029)
Figure 23. United States Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Dengue Vaccines Market Share by Country (2018-2029)
Figure 27. Germany Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Dengue Vaccines Market Share by Country (2018-2029)
Figure 35. China Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Dengue Vaccines Market Share by Country (2018-2029)
Figure 43. Mexico Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Dengue Vaccines Market Share by Country (2018-2029)
Figure 47. Turkey Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Dengue Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Sanofi Revenue Growth Rate in Dengue Vaccines Business (2018-2023)
Figure 51. Takeda Revenue Growth Rate in Dengue Vaccines Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings